APA (7 ম সংস্করণ) উদ্ধৃতি

Chakravarthy, U., Harding, S., Rogers, C., Downes, S., Lotery, A., Wordsworth, S., & Reeves, B. (2012). Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Chakravarthy, U., S. Harding, C. Rogers, S. Downes, A. Lotery, S. Wordsworth, এবং B. Reeves. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

Chakravarthy, U., et al. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.